ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

KYMR Kymera Therapeutics Inc

45.98
0.00 (0.00%)
Pre Market
Last Updated: 09:10:24
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 16.14M9.47M16.51M4.73M47.89M10.29M25.65M3.74M
Operating Income -38.63M-45.33M-43.38M-57.51M-19.31M-52.91M-50.93M-72.12M
Pre Tax Income -34.87M-40.93M-38.8M-52.87M-14.37M-48.56M-42.06M-62.49M
Net Income -34.87M-40.93M-38.8M-52.87M-14.37M-48.56M-42.06M-62.49M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -38.63M-45.33M-43.38M-57.51M-19.31M-52.91M-50.93M-72.12M
EBITDA -37.85M-44.45M-42.48M-55.49M-19.55M-51.45M-48.99M-70.14M
Year End 31 December 2023 201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 02.93M34.03M72.83M46.83M78.59M
Operating Income -21.45M-42.21M-46.3M-100.53M-161.26M-165.53M
Pre Tax Income -21.47M-41.25M-45.59M-100.22M-154.81M-146.96M
Net Income -21.47M-41.25M-54.64M-100.22M-154.81M-146.96M
Preferred Dividends 00-9.05M000
Basic Earnings Per Share (EPS) -9.1-13.405-1.219-1.945-2.813-2.649
EBIT -21.45M-42.21M-46.3M-100.53M-161.26M-165.53M
EBITDA -21.25M-41.38M-44.54M-98.13M-158.28M-161.97M